4.2 Editorial Material

Testosterone replacement therapy and cardiovascular risk factors modification

Journal

AGING MALE
Volume 14, Issue 2, Pages 83-90

Publisher

TAYLOR & FRANCIS LTD
DOI: 10.3109/13685538.2010.541538

Keywords

Hypogonadism; testosterone replacement therapy; cardiovascular risk factors; heart failure

Ask authors/readers for more resources

Hypogonadism in males is associated with increased atherosclerotic disease. Physiologically, testosterone appears to have both positive and negative effects on the cardiovascular system. Testosterone decreases angina and may improve the cardiac healing response after myocardial infarction. Testosterone enhances function in males with heart failure (HF). Testosterone causes water retention and oedema is common in older persons. Oedema should not be used to diagnose HF in older persons. Studies in older persons with HF and frailty have shown a non-statistically lower mortality rate compared to those receiving placebo.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available